Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
CBIZ
CBZ
$2.96B
| $13M | 0.01% |
482,927
-139,699
| -22% | -$3.63M |
|
1277
SiteOne Landscape Supply
SITE
$4.31B
| $13M | 0.01% |
+143,600
| New | +$12.2M |
|
1278
NVE Corp
NVEC
$578M
| $13M | 0.01% |
182,000
+11,800
| +7% | +$769K |
|
|
QEP
1279
DELISTED
QEP RESOURCES, INC.
QEP
| $13M | 0.01% |
+2,886,800
| New | +$10.1M |
|
1280
Zai Lab
ZLAB
$2.9B
| $13M | 0.01% |
311,631
-57,000
| -15% | -$2.1M |
|
1281
Dime Commercial Bancshares
DCOM
$1.82B
| $13M | 0.01% |
386,300
+105,500
| +38% | +$3.39M |
|
1282
Peapack-Gladstone Financial
PGC
$824M
| $12.9M | 0.01% |
418,620
+28,300
| +7% | +$833K |
|
1283
Bassett Furniture
BSET
$170M
| $12.9M | 0.01% |
774,505
-2,100
| -0.3% | -$32.6K |
|
1284
Bankunited
BKU
$3.43B
| $12.9M | 0.01% |
353,200
-198,600
| -36% | -$6.92M |
|
|
ACH
1285
Accendra Health
ACH
$82.3M
| $12.9M | 0.01% |
2,493,250
+1,240,216
| +99% | +$7.96M |
|
|
STAY
1286
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $12.9M | 0.01% |
867,117
+501,316
| +137% | +$7.3M |
|
|
ORC
1287
Orchid Island Capital
ORC
$1.33B
| $12.9M | 0.01% |
440,359
+70,000
| +19% | +$2.01M |
|
|
MTOR
1288
DELISTED
MERITOR, Inc.
MTOR
| $12.9M | 0.01% |
491,200
+337,800
| +220% | +$7.62M |
|
1289
Universal Technical Institute
UTI
$1.38B
| $12.9M | 0.01% |
1,668,196
+107,734
| +7% | +$649K |
|
1290
Simulations Plus
SLP
$371M
| $12.8M | 0.01% |
441,800
-59,800
| -12% | -$2.03M |
|
|
HOUS
1291
DELISTED
Anywhere Real Estate
HOUS
| $12.8M | 0.01% |
1,326,415
+624,215
| +89% | +$5.73M |
|
|
MRC
1292
DELISTED
MRC Global
MRC
| $12.8M | 0.01% |
940,771
+340,871
| +57% | +$4.44M |
|
1293
Hexcel
HXL
$7.8B
| $12.8M | 0.01% |
174,100
+7,400
| +4% | +$568K |
|
1294
Allient
ALNT
$1.88B
| $12.7M | 0.01% |
394,151
+36,101
| +10% | +$1.01M |
|
1295
Transocean
RIG
$6.61B
| $12.7M | 0.01% |
1,847,200
-196,300
| -10% | -$1.01M |
|
1296
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $12.7M | 0.01% |
236,845
+90,446
| +62% | +$4.85M |
|
1297
Rush Enterprises Class B
RUSHB
$9.37B
| $12.7M | 0.01% |
624,150
-12,375
| -2% | -$240K |
|
|
GWB
1298
DELISTED
Great Western Bancorp, Inc.
GWB
| $12.6M | 0.01% |
363,584
-60,271
| -14% | -$2.08M |
|
1299
Titan International
TWI
$434M
| $12.6M | 0.01% |
3,485,840
+162,140
| +5% | +$483K |
|
|
SWIR
1300
DELISTED
Sierra Wireless
SWIR
| $12.6M | 0.01% |
1,316,000
+308,249
| +31% | +$3M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.